https://www.selleckchem.com/pr....oducts/elexacaftor.h
5%, = 0.019 in the ITT analysis; 89.3%, = 0.022 in the PP analysis). In subgroup analysis of peptic ulcer patients, the success rate of BQ group was significantly higher than that of MRT group in both ITT and PP populations (81.8% (108/132) vs. 60.8% (31/51) in the ITT populations, = 0.004; and 90.0% (108/12 vs. 72.1% (31/43) in the PP populations, = 0.01. Among the 14 patients with MRT therapy failure, 10 were eradicated with BQ as the third-line regimen. The eradication rate of the third-line BQ after the second-line MRT f
Like
Comment
Share
